Related Experiment Video
Updated: Jul 29, 2025

06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
829
Hormonal contraception & face processing: Examining face gender, androgenicity & treatment duration
Belinda Pletzer1, Isabel Noachtar1, Esmeralda Hidalgo-Lopez1
1Department of Psychology & Centre for Cognitive Neuroscience Paris-Lodron-University of Salzburg, Salzburg, Austria.
Psychoneuroendocrinology
|May 21, 2023
Summary
Combined oral contraceptive (COC) use impacts face processing, particularly connectivity in the fusiform face area (FFA). Effects depend on androgenicity and do not persist after stopping COCs.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Endocrinology
Background:
- Previous studies indicate combined oral contraceptives (COCs) may alter face processing.
- The fusiform face area (FFA) and its functional connectivity are implicated.
- Understanding these effects requires differentiating COC types and usage duration.
Purpose of the Study:
- To investigate the impact of different combined oral contraceptive (COC) types on face processing.
- To examine the relationship between COC use duration, androgenicity, and neural activity in the FFA.
- To explore alterations in brain connectivity associated with face recognition during COC use.
Main Methods:
- 120 female participants underwent structural and functional MRI scans (rest, face encoding, face recognition).
- Participants were categorized as never-users, current first-time users, or previous users of androgenic or anti-androgenic COCs.
- Analysis focused on the fusiform face area (FFA) and its connectivity, particularly with the supramarginal gyrus (SMG).
Main Results:
- COC-associated effects on face processing are modulated by androgenicity and cease after use.
- Anti-androgenic COC users showed altered resting-state FFA-SMG connectivity compared to never-users.
- Androgenic COC use correlated with decreased FFA-SMG connectivity during face recognition and reduced identification accuracy with longer duration.
Conclusions:
- Combined oral contraceptive (COC) use influences face processing networks, with effects varying by androgenicity.
- The fusiform face area (FFA) and supramarginal gyrus (SMG) are key regions affected by COC use.
- Findings highlight the need for further research, including randomized controlled trials, on COC effects on cognitive functions.
Related Concept Videos
Hormonal Regulation of the Menstrual Cycle
502
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
502
Target Cell Response to Hormones
3.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
Birth Control Methods
377
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
377
Hormonal Control of the Ovarian Cycle
595
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
595
Menopause
210
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
210
Signs of Puberty
473
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
473

